About KURESYS LABS
KURESYS LABS is a Healthcare company based in Delhi (India) by Ranjit Singh. It produces high-quality finished dosage form products for the pharmaceutical industry. It operates on a B2B model. The company has 37 employees. Its Indian entity Kuresys Labs Private Limited reported revenue of ₹4.26 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Dosage Forms. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
KURESYS LABS, based in Delhi, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and dosage forms. Produces high-quality finished dosage form products for the pharmaceutical industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Delhi, India
- Employees 37
- Founders Ranjit Singh
- SectorsHealthcare
- Website kuresyslabs.com
- Legal Name Kuresys Labs Pvt. Ltd
- Date of Incorporation 21 Mar, 2014
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹4.26 Cr
FY 2025 · -6% YoY
- Net Loss-₹16.1 Lakh
FY 2025 · -4% margin
- EBITDA-₹7.3 Lakh
FY 2025 · -2% margin
- Employee Count37
Associated legal entities of KURESYS LABS
KURESYS LABS operates through Kuresys Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kuresys Labs Private Limited CIN U24100DL2014PTC266735 | Active | 21 Mar 2014 | New Delhi, Delhi | ₹4.3 Cr | 37 | 2 | View details |
Board of directors of Kuresys Labs Private Limited (KURESYS LABS)
Kuresys Labs Private Limited is the primary company behind KURESYS LABS. The board of Kuresys Labs Private Limited currently have 2 directors; the longest-serving is Ranjit Singh, appointed in 2014. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ranjit Singh DIN 06828826 | Director | 21 Mar 2014 | 12 yrs 6 mo | Kuresys Labs Private Limited |
| Anamika Keswal DIN 09157837 | Director | 26 Apr 2021 | 5 yrs 5 mo | Kuresys Labs Private Limited |
People of KURESYS LABS
1 people are tracked at KURESYS LABS (1 in leadership); the tracked headcount is 37.
| Name | Role | Group |
|---|---|---|
| Founder | Leadership |
Complete people profiles for KURESYS LABS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of KURESYS LABS
Figures of Kuresys Labs Private Limited, the primary company behind KURESYS LABS, for FY 2025. Revenue was ₹4.26 Cr (-6% year on year). Net loss was -₹16.1 Lakh (-4% margin). EBITDA was -₹7.3 Lakh (-2% margin). Revenue has grown at a compounded annual rate of +15% over three years and -8% over five years.
- ₹4.26 CrRevenue · FY 2025 · -6% YoY
- -₹16.1 LakhNet loss · -4% margin
- -₹7.3 LakhEBITDA · -2% margin
- ₹10 LakhPaid-up capital
- 37Employees (provident fund records)
- +15%Revenue CAGR, 3 years
- -8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Kuresys Labs Private Limited are on its company page.
Detailed financial statements for KURESYS LABS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of KURESYS LABS
KURESYS LABS has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of KURESYS LABS
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as KURESYS LABS (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about KURESYS LABS
KURESYS LABS is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
KURESYS LABS has 37 employees.
The primary company behind KURESYS LABS, Kuresys Labs Private Limited, reported revenue of ₹4.26 Cr for FY 2025, down 6% year on year.
KURESYS LABS, based in Delhi, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and dosage forms. Produces high-quality finished dosage form products for the pharmaceutical industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
KURESYS LABS's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
KURESYS LABS operates through Kuresys Labs Private Limited.
The legal entities of KURESYS LABS currently have 2 directors, including Anamika Keswal, Ranjit Singh.